‘Modem Mayhem’: Why Millions May Miss Out on NBN’s Big Speed Upgrade
Millions of Australians are at risk of missing out on the full benefits of the NBN’s major speed upgrade due to outdated home equipment and patchy infrastructure. While NBN Co is rolling out significant speed boosts—raising popular plans from 100Mbps to 500Mbps, and introducing ultra-fast tiers up to 2000Mbps—many households won’t be able to take full advantage.
The biggest issue? Modems and routers. A large number of homes are still using old or entry-level Wi-Fi equipment, much of it incapable of handling high-speed connections. Some devices are limited to speeds well below 100Mbps, meaning users could be paying for premium internet they can’t actually use. Even newer routers may struggle in larger or multi-storey homes unless supported by mesh systems or upgraded Wi-Fi technology.
Infrastructure is another limiting factor. While fibre-to-the-premises (FTTP) connections can support the fastest speeds, many households are still connected via fibre-to-the-node (FTTN) or fibre-to-the-curb (FTTC), which rely on ageing copper lines and cap performance. Although NBN is offering free fibre upgrades to eligible customers, the program rollout is gradual and not yet available everywhere.
A further complication is confusion around responsibility. Many consumers assume internet providers are responsible for in-home network performance, but in reality, users must ensure their own hardware is compatible with higher speeds. Some providers offer better modems or mesh Wi-Fi systems with premium plans, but these often come at an added cost.
Unless action is taken, a significant portion of the population may find themselves locked out of the NBN speed revolution. To avoid missing out, Australians are being encouraged to check their modem’s capabilities, understand their connection type, and upgrade equipment where necessary to unlock the full potential of faster internet.
Goodbye Accountants? Airwallex Unveils Plans for AI-Powered CFOs
Airwallex, the Australian fintech company valued at over $6 billion, is set to revolutionise financial operations with its upcoming suite of AI-driven tools designed to serve as virtual Chief Financial Officers (CFOs) for modern businesses. This move aims to automate complex financial tasks, providing small and medium-sized enterprises (SMEs) with the capabilities traditionally reserved for large corporations.
The new suite, currently in beta testing, integrates artificial intelligence across various financial functions. Features include automated bookkeeping, real-time financial insights, compliance tracking, and spend management. These tools are designed to streamline financial operations, reduce manual errors, and offer SMEs a comprehensive view of their financial health.
CEO Jack Zhang emphasised the company’s commitment to an AI-first approach, stating that every team member is encouraged to rethink workflows and integrate AI into daily tasks. This initiative reflects Airwallex’s broader strategy to position itself as a leader in the next generation of financial services, blending automation with human oversight to enhance efficiency and decision-making.
While the introduction of AI-powered CFOs may raise concerns about job displacement in traditional accounting roles, experts suggest that these tools are more likely to augment human capabilities rather than replace them. By automating routine tasks, accountants can focus on strategic planning and advisory services, adding greater value to their clients.
As Airwallex prepares for the global release of its AI-driven financial suite, businesses are encouraged to assess their readiness for such technological advancements. Embracing these innovations could be pivotal in maintaining competitiveness in an increasingly digital financial landscape.
Amazon’s AI Problem: Fake Authors Flooding the Marketplace
Amazon’s Kindle Direct Publishing (KDP) platform, once a beacon for independent authors, is now grappling with an influx of AI-generated books that mimic real authors, often flooding bestseller lists and misleading readers.
These AI-generated titles frequently appear under the guise of well-known authors or with generic names, often accompanied by AI-generated cover art. The content is typically shallow, lacking original insight, and sometimes riddled with factual inaccuracies. Despite these red flags, many of these books manage to climb Amazon’s bestseller lists, sometimes even surpassing legitimate works in visibility.
For instance, tech journalist Kara Swisher discovered multiple AI-generated biographies bearing her name, complete with fabricated content and misleading descriptions. Similarly, other authors have found their names used for AI-generated works that misrepresent their expertise or content.
Amazon has acknowledged the issue and implemented measures such as limiting self-publishers to three uploads per day. However, critics argue that these steps are insufficient and that Amazon needs to do more to distinguish AI-generated content from authentic works.
The proliferation of AI-generated books raises significant concerns about the integrity of digital publishing platforms and the potential for consumer deception. As AI technology continues to advance, it’s imperative for platforms like Amazon to develop more robust systems to ensure that readers can trust the authenticity of the content they purchase.
In conclusion, while AI offers exciting possibilities for content creation, its misuse in the realm of digital publishing highlights the need for stricter regulations and oversight to protect both authors and readers.
Aussie Biotech’s Breakthrough Could Replace Painful Blood Tests
Australian researchers have unveiled a groundbreaking advancement in medical diagnostics—a non-invasive blood test that could revolutionize patient care by eliminating the need for traditional, painful blood draws. This innovative technology leverages advanced biosensor technology to detect biomarkers through a simple skin prick, offering a more comfortable and accessible alternative for patients.
The new device, developed by a team of scientists from Monash University, is designed for use in general practice settings. It utilizes a handheld, credit card-sized sensor that can quickly analyze a drop of blood to detect disease markers. This method not only reduces patient discomfort but also has the potential to expedite the diagnostic process, allowing for quicker decision-making and treatment initiation.
Associate Professor Sudha Mokkapati, who led the development of the device, emphasized its potential to streamline healthcare delivery. “The simplicity and speed of this test could significantly enhance the efficiency of medical practices, making early detection of various conditions more accessible,” she stated.
Clinical trials have demonstrated the device’s accuracy in identifying multiple health conditions, including early-stage Alzheimer’s disease, by detecting specific biomarkers in the blood. The ability to perform such tests at the point of care could reduce the reliance on specialized laboratories and decrease waiting times for results.
While the technology shows great promise, experts caution that further validation and regulatory approvals are necessary before it can be widely implemented in clinical settings. Nonetheless, this development marks a significant step forward in the pursuit of non-invasive diagnostic methods, potentially improving patient experiences and outcomes across various medical disciplines.
